Market Tracker

01/23 5:16pm ET

Seattle Genetics Inc (NASDAQ:SGEN)

58.52
Delayed Data
As of 3:59pm ET
 -0.27 / -0.46%
Today’s Change
26.02
Today|||52-Week Range
75.36
+10.90%
Year-to-Date

Today’s Trading

Previous close58.79
Today’s open58.69
Day’s range57.76 - 59.57
Volume516,488
Average volume (3 months)1,242,053
Market cap$8.3B
Dividend yield--
Data as of 3:59pm ET, 01/23/2017

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)-0.97%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+17.45%
P/E ratioNM
Price/Sales17.21
Price/Book11.97

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc-0.24-0.43%
TSROTESARO Inc-0.91-0.62%
RDYDr.Reddy's Laborator...-0.34-0.78%
JAZZJazz Pharmaceuticals...-2.45-1.98%
Data as of 4:14pm ET, 01/23/2017

Financials

Next reporting dateFebruary 10, 2017
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$336.8M
Annual profit (last year)-$120.5M
Net profit margin-35.77%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts